[PDF] Top 20 Arq Bras Endocrinol Metab vol.50 número6

... N a SBEM, trabalhamos, também, para melhorar nossa comunicação com a sociedade, usando todos os meios disponíveis, principalmente a mídia.. Acreditamos ser fundamental que todos saibam q[r] ... See full document

... The aim of this study is to assess the effects of sibutramine (S) 15 mg/day, flu- oxetine (F) 60 mg/day, and metformin (M) 1,700 mg/day, as an adjunct therapy to a 1,500 kcal/day diet, in reducing anthropometric and ... See full document

... N esse contexto, serão devidamente desenvolvidos programas de educação médica continuada, tanto na forma presencial como via internet, tornando o processo de educação médica continuada o[r] ... See full document

... O uso diário de aspirina em pacientes com diabetes mellitus do tipo 2 (DM2) reduz significantemente os eventos cardiovasculares (ECV). Na ausência de contraindicações, a ADA (American Diabetes Association) recomenda o ... See full document

... (Arq Bras Endocrinol Metab 2006:50/ 2:) esta foi extensiva- mente estudada, mas, devido à ausência de trabalhos abordando sua relação com transtornos psiquiátricos, os autores se viram ... See full document

... Osteoporosis is a common disease that is associated with increased risk of fractures and serious clinical consequences. Bone mineral density (BMD) testing is used to diagnose osteoporosis, estimate the risk of frac- ... See full document

... Na edição de Abril de 2006, o artigo de Luciana Bahia e colaboradores — “O Endotélio na Síndrome Metabólica” (Arq Bras Endocrinol Metab 2006; 50/2:291-303), por uma falha na diagramação[r] ... See full document

... (Arq Bras Endocrinol Metab 2006;50/2:198-207) Descritores: Peptídeos natriuréticos; ANP, BNP e CNP; Guanilil-ciclase e receptores de clareamento; Homeostase pressão arterial-volume; ... See full document

... Brown tumors are relatively uncommon but they are serious complica- tions of renal osteodystrophy. We describe a 31-year-old woman with end-stage renal disease who had undergone hemodialysis for nine years and developed ... See full document

... Only a small fraction of the total renal oxalate burden each day comes from absorbed oxalate; nevertheless, variations in that quantity appear to have a significant effect on kidney stone risk. Curhan et al., a number of ... See full document

... The WHI demonstrated unequivocally that estrogen, with or without progestin, reduced fracture risk. The WHI was a randomized, double blind placebo-con- trolled multicenter study. There were two studies, the first of ... See full document

... Osteoporosis is a metabolic disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk. Bone fragility ... See full document

... Objetivo: Analisar a relação entre obesidade e taxa de excreção urinária de albumina (TEUA). Métodos: Este é um estudo de corte de 73 pacientes com diabetes tipo 2 (DM) normoalbuminúricos (TEUA < 20 µg/min), que foram ... See full document

... Initial retrospective (107) and prospective studies (108,109) that compared tamoxifen-treated women against the placebo group, found no signifi- cant differences in BMD at the lumbar spine or femoral neck. Subsequent ... See full document

... não deixará de prover os recursos e meios para que o Corpo Editorial possa desenvolver adequadamente seu trabalho, que em última análise objetiva dar maior vi- sibilidade internacional à[r] ... See full document

... The effect of Alendronate on fracture incidence was evaluated in the randomized, double-blind, place- bo-controlled Fracture Intervention Trial (FIT) (21). Among patients with ≥ 1 baseline radiographic verte- bral ... See full document

... Objective: To analyze tests used in routine clinical practice for the diagnosis of myocardial ischemia to predict the development of cardiac events in type 2 diabetic patients. Methods: The occurrence of cardiac events ... See full document

... disease characterized by low bone mass and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture” (1). Approximately 40–50% of women sustain ... See full document

... PTH(1-84) has been the object of a limited number of studies. In a preliminary clinical trial, preparatory to the definitive clinical trial, subjects were administered place- bo, or 1 of 3 doses of PTH(1-84): 50, ... See full document

... (33,34). In women with pre-existing vertebral frac- tures, alendronate therapy reduced the incidence of vertebral, hip and wrist fractures by about 50% (table 2), and the risk of multiple vertebral fractures was ... See full document